With our current procedure we cannot rule out that the origin of peripheral CD8+ HLA-DR+ T cells is the tumor microenvironment and, therefore, BC plasma in vitro cannot upregulate HLA-DR expression. The gene discussed is CD8A; the disease is neoplasm.